New flow reactor heater allows high-speed, multi-step reactions in
front of your eyes allowing users to monitor progress and intervene
in case problems to avoid time and reagent waste.
The dream of personalised medicine has taken another step towards
reality as scientists have developed an innovative nanomechanical
sensor for detecting disease and observing the body's reaction to
treatment.
A federal scientist has been charged with criminal conflict of
interest after he allegedly performed consultancy work that
improperly overlapped with government work.
A more spontaneous future for sufferers of erectile dysfunction has
been heralded by the successful completion of a Phase I clinical
trial of a new gene therapy which could provide six months' effect
with a single dose.
Swiss custom manufacturer Lonza and Singapore's BioOne Capital have
announced a new joint venture to build a $350m (€263m) large-scale
manufacturing facility in Singapore.
Millipore has introduced a new container film - PureFlex - that
ties in with the trend towards increasing use of disposable
products within the bioprocessing sector.
AAIPharma has announced it has signed a contract manufacturing
agreement with Mallinckrodt Pharmaceuticals Outsourcing which aims
to provide a "one-stop drug development solution" for drug makers.
The contract research organisation (CRO) industry is in full swing
as the clinical trial outsourcing trend continues, but where is the
money being spent?
A hefty investment by Pfizer in an Irish manufacturing facility
could prove to be a waste after the potential blockbuster it was
designed to make has been canned.
Evotec AG has sold its cell analysis instrument division, Evotech
Technologies, to PerkinElmer to allow it to focus more keenly on
its drug discovery pipeline and drug discovery services divisions.
Rockwood Holdings announced last week that it has reached an
agreement to sell its subsidiary Groupe Novasep to a consortium of
buyers in a transaction valued at €425m.
A US research company has published a report placing clamshell
style packaging as the forerunner in the burgeoning high visibility
packaging industry, with blister packs also on the increase.
France has placed itself firmly at the forefront of research into
personalised medical solutions for cancer, infectious diseases and
rare genetic diseases by investing nearly half a billion euros into
the ADNA project.
Canadian pharma manufacturer Bioxel has announced it has received
several orders for its paclitaxel product - a taxane-based drug
effective to treat cancer - from two European customers
representing a total of CAD$630,000 (€420,000).
Cardinal Health, the leading contract manufacturer for the
pharmaceutical industry, has announced its plans to sell its drug
manufacturing and packaging unit in order to focus on its
health-care business.
Biotech company Progen has decided to manufacture its new
anti-cancer drug in-house rather than outsource it in order to save
on costs after the FDA gave the thumbs up for the manufacture of
the drug for its upcoming phase III clinical...
Tripos has announced the sale of its Discovery Informatics
Business, as an initial step towards liquidation, in light of the
current trend to low-cost Asian outsourcing.
ReSearch Pharmaceutical Services (RPS), a US based outsourcing
company, has announced expansion plans in Latin America. This
reflects the increasing trend of pharmaceutical companies
exploiting the cost benefits associated with outsourcing...
The necessity for drug manufacturers to comply with increasingly
rigorous regulations is driving laboratory information management
systems (LIMS) growth, according a new study.
British chemical products and technologies firm Reaxa has launched
a new encapsulated catalyst for market trials. Platinum EnCat is a
platinum nanoparticle catalyst encapsulated within polymer beads,
intended for the hydrogenation...
The recent discovery of master cardiac stem cells with the capacity
to produce all three major heart tissue types brings heart tissue
regeneration after injury a step closer.
Dutch biotech company Crucell said last week that it had completed
its acquisition of SBL Vaccin in an agreement worth €39.4m, but
remained tight-lipped about its plans for the Swedish firm's
contract manufacturing business.
Major drug companies across the US have scrambled to reformulate
their over-the-counter cold medications in time for a new law that
came in to effect in September, however, there are claims that the
new formulations are a flop.
MultiCell Therapeutics, a recent US spin-out, has designed an
anticancer therapy that has been shown in animal models to
completely destroy malignant tumours, even when very advanced.
US drug developer Samaritan Pharmaceuticals has filed a patent for
a new drug that could treat a wide range of neurodegenerative
disorders, including Alzheimer's disease, by clearing out amyloid
plaques in the brain.
A cell preservation solution that makes research using kidney cells
easier to carry out, developed by UK firm Abcellute, has been made
available on the Japanese market. Abcellute licensed Japanese
rights to the product to GeneFrontier,...
Actavis has announced its majority purchase of Russian
pharmaceutical manufacturer, ZiO Zdorovje, in a move set to
establish the company's presence in the growing Russian generics
market.
Granules India and Biocause have signed an agreement to create a 50
: 50 joint venture entity to manufacture and sell pharmaceutical
APIs (Active Pharmaceutical Ingredients), starting with Ibuprofen.
Scientists have found a computational method that charts chemical
space in the search for new breast cancer treatments. The technique
has already resulted in the discovery of compounds that have
performed better than current standard...
Scientists have managed to gain unique insights into the future
design of drugs for a selection of medical conditions using
innovative NMR equipment to study a range of biological processes.
A new X-ray microscopy technique will enable scientists to view
materials less than a nanometre in size. The development will help
scientists visualise reactions at surfaces, such as corrosion and
catalytic reactions, in real-time.
Bayer Diagnostics and Innogenetics have launched an assay that
allows genotyping for the Hepatitis C Virus (HCV), permitting
broader identification of HCV genotypes with improved accuracy, not
possible by current HCV genotyping products.
Surface Logix has presented encouraging Phase 1 trial data for a
drug candidate that is being developed for the treatment of
abnormal levels of lipids in the bloodstream - a condition that
affects approximately 10 per cent of the...
Novo Nordisk is planning to sue the head of the US Patent and
Trademark Office after its inhaled insulin product has had its
patent application knocked back for the second time.